Research Article

|

2019, 12(12): 2971–2981

|

https://doi.org/10.1007/s12274-019-2540-3

All-in-one theranostic nanoplatform with controlled drug release and activated MRI tracking functions for synergistic NIR-II hyperthermiachemotherapy of tumors

Xianguang Ding1,, Haitao Zhao2, Chunyan Li1,3, Qiangbin Wang1,3, and Jiang Jiang1,3 (*)

View Author's information

1 i-Lab and Division of Nanobiomedicine, CAS Key Laboratory of Nano-Bio Interface, CAS Center for Excellence in Nanoscience, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, China
2 Institute for Health Innovation and Technology, National University of Singapore, Singapore 117599, Singapore
3 School of Nano Technology and Nano Bionics, University of Science and Technology of China, Hefei 230026, China
Present address: Institute for Health Innovation and Technology, National University of Singapore, Singapore 117599, Singapore

Keywords: hyperthermia, magnetic resonance, NIR-II window, drug delivery, chemotherapy
Full article PDF
Cite this article(Endnote)
Share this article
Metric

views: 181

Citations: 0

  • Abstract
  • References
  • Electronic Supplementary Material
Real-time tracking drug release behavior is fundamentally important for avoiding adverse effects or unsuccessful treatment in personalize medical treatment. However, the development of a non-invasive drug reporting platform still remains challenging. Herein the design of a novel synthetic magnetic resonance imaging (MRI) agent for drug release tracking (SMART) is reported, which integrates photothermal core and paramagnetic ion/drug loading shell with a thermal valve in a hybrid structure. Through near-infrared (NIR)-II photothermal effect originating from inner Au-Cu9S5 nanohybrid core, burst release of drugs loaded in the mesoporous silica shell is achieved. The concomitant use of a phase change material not only prevents premature drug release, but also regulates heating effect, keeping local temperature below 45 oC, enabling synergistic chemotherapy and mild hyperthermia in vitro and in vivo. Furthermore, the drug release from SMART facilitates proton accessibility to the paramagnetic ions anchored inside mesopores channels, enhancing longitudinal T1 relaxation rate and displaying positive signal correlation to the amount of released drug, thus allowing non-invasive real-time monitoring of drug release event. The current study highlights the potential of designed MRI nanophores such as SMART for real-time and in-situ monitoring of drug delivery for precision theranostic applications.
Related Article
Cite this article

All-in-one theranostic nanoplatform with controlled drug release and activated MRI tracking functions for synergistic NIR-II hyperthermiachemotherapy of tumors. Nano Res. 2019, 12(12): 2971–2981 https://doi.org/10.1007/s12274-019-2540-3

Download citation